Good Lifestyle

Once you are in the habit, take a prescription Each day becomes a fairly insane task. In this spirit, you probably do not think of inspecting the pills themselves, especially since certain drugs comply with different shapes and colors depending on whether you get branding or generic varieties during a given month. But errors occur, and now, attention / hyperactivity deficit disorder (ADHD) and Zenzedi narcolepsy drugs were recalled after an erroneous error during manufacturing.

In relation: New major recall of the Robutin cough syrup for "contamination", warns the FDA .

According to a January 24 alert From the US Food and Drug Administration (FDA), Azurity Pharmaceuticals, based in Massachusetts, recalls a lot of dextroamphetamine sulfate tablets, USP in the dose of 30 milligrams. The drug, which is a controlled substance of Annex II and known to the Zenzedi brand name, is prescribed to treat ADHD as well as narcolepsy, according to the FDA.

The drugs were recalled after a Nebraska pharmacist opened a bottle of 30 mg Zenzedi tablets and rather found carbinoxamine maleate, which is an antihistamine drug, by the FDA. The manufacturer then opened a product complaint and started an investigation. The recalled products were distributed nationally through pharmacies.

The FDA warns that those who without knowing carbinoxamine can live unwanted events "which include, but without limiting itself, drowsiness, drowsiness, depression of the central nervous system (SNC), increased pressure Eye, the urinary obstruction of the enlarged prostate and thyroid disorder. "

Those who prescribe zenzedi and take carbinoxamine in place will also subcontract their symptoms, which could lead to "functional impairment and increased risk of accidents or injuries," said the agency.

"For patients with hyperactivity disorder with attention deficit (ADHD) and narcolepsy (sleep disorder), there is a reasonable probability that accidents or injuries that occur due to the sedative effects that Use (ignoring that they have not received from Zenzedi®) engage in significant concentration and vigilance (for example, driving, operating heavy machines), "said the FDA alert.

In relation: Analgesic spray recalled on a chemical cancer cancer, warns the FDA . AE0FCC31AE342FD3A1346EBB1F342FCB

To be safe, you will return to the pills you have at home if you are prescribed this medication. The 30 mg Zenzedi tablets are light -yellow hexagonal tablets that have "30" on one side and "MIA" on the other. They are distributed in white bottles and have "30 mg" highlighted in yellow. You can distinguish them from the tablets of Maleat Carbinoxamine USP, 4 mg of tablets, which are white round tablets with "GL" on one side and "211" on the other side.

The batch recalled has a national number of drugs (NDC). At home, stop using them and return to your place of purchase, says the FDA.

Since the FDA alert of January 24, Azurity had not received any report of serious adverse events related to the recall. But if you encounter problems, you must contact your doctor or health care provider and report the unfavorable event to Azurity by e-mail ( [Protected by e-mail] ). The FDA also asks you that you report unwanted reactions or quality problems to its MEDWATCH unwanted event reports program online , or via Mail or fax .